Geneva Advisors’s Cavium, Inc. CAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$964K Buy
15,521
+487
+3% +$34K 0.02% 365
2017
Q1
$1.08M Buy
15,034
+746
+5% +$49.9K 0.02% 340
2016
Q4
$892K Buy
14,288
+893
+7% +$51.5K 0.02% 364
2016
Q3
$780K Buy
13,395
+285
+2% +$14.3K 0.01% 376
2016
Q2
$506K Sell
13,110
-7,026
-35% -$347K 0.01% 442
2016
Q1
$1.23M Buy
20,136
+8,906
+79% +$514K 0.02% 260
2015
Q4
$738K Buy
+11,230
New +$758K 0.01% 349

Other funds holding CAVM

Geneva Advisors's CAVM Position: Q2 2017 in Review

Geneva Advisors increased its Cavium, Inc. (CAVM) stake by 3.2% in Q2 2017, buying an estimated $34K and bringing the position to 15,521 shares worth $964K. The position accounts for 0.02% of the portfolio, ranked #365.

Geneva Advisors first reported a position in CAVM in Q4 2015 and has held it in 7 quarters since. The position peaked at $1.23M in Q1 2016. 250 funds tracked by Wall St. Rank hold CAVM as of Q2 2017.

  • Geneva Advisors held 15,521 shares of Cavium, Inc. worth $964K as of Q2 2017.
  • Geneva Advisors bought 487 Cavium, Inc. shares in Q2 2017, an estimated $34K.
  • Cavium, Inc. made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #365 holding.
  • Geneva Advisors first reported a position in Cavium, Inc. in Q4 2015 and has held it in 7 quarters since.
  • Geneva Advisors's Cavium, Inc. position peaked at $1.23M in Q1 2016.
  • 250 funds tracked by Wall St. Rank held Cavium, Inc. as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.